Results 81 to 90 of about 3,295,340 (243)

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li, Max Homilius, Erin Achilles, Laura K. Massey, Victoria Convey, Åsa Ohlsson, Ingrid Ljungvall, Jens Häggström, Brittany Vester Boler, Pascal Steiner, Sharlene Day, Calum A. MacRae, Mark A. Oyama   +12 more
wiley   +1 more source

Clinical Effect of the Modified Morrow Septal Myectomy Procedure for Biventricular Hypertrophic Cardiomyopathy

Reviews in Cardiovascular Medicine
Background: Right ventricular involvement in hypertrophic cardiomyopathy is uncommon. This study aimed to evaluate clinical outcomes of the modified septal myectomy in patients diagnosed with biventricular hypertrophic cardiomyopathy (BHCM), a subject ...
Tong Tan, Wei Zhu, Jianrui Ma, Bingqi Fu, Xiaodong Zeng, Ruobing Wang, Xiaoyi Li, Jian Liu, Jian Zhuang, Jimei Chen, Huiming Guo   +10 more
doaj   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Fungal Pulmonary Valve Endocarditis Masquerading as a Pulmonary Embolism

Case Reports in Surgery, 2015
Septic pulmonary emboli (SPE) can be a difficult clinical entity to distinguish from thromboembolic pulmonary embolism (TPE) in a patient with history of IV drug abuse (IVDA).
Kevin B. Ricci, Peter H. U. Lee, Michael Essandoh, Ahmet Kilic   +3 more
doaj   +1 more source

Large pseudoaneurysm following right ventricle to pulmonary artery homograft placement in an infant

Annals of Pediatric Cardiology, 2018
Pseudoaneurysm (PSA) is a known but rare complication of the right ventricle to pulmonary artery (RV-PA) conduits. The patient's clinical presentation can be variable ranging from asymptomatic to potential rupture.
Rini Sahewalla, Robert D Ross, Ralph E Delius, Ryan Halas, Premchand Anne   +4 more
doaj   +1 more source

Video_1_Case report: Right ventricular outflow tract obstruction caused by multicomponent mesenchymal tumor.AVI

, 2022
Right ventricular outflow tract obstruction (RVOTO) is a cause of hemodynamic instability that can lead to right ventricular dysfunction. Cardiac tumors located in the right ventricle or surrounding structures can cause RVOTO.
Shengyuan Huang (13776577), Shiye Wang (13776580), Zhixiang Tang (4397125), Yinghuan Dai (12879608), Long Song (4251634)   +4 more
core   +1 more source

Pulmonary Valve Regurgitation: Neither Interventional Nor Surgery Fits All

Frontiers in Pediatrics, 2018
Introduction: PV implantation is indicated for severe PV regurgitation after surgery for congenital heart defects, but debates accompany the following issues: timing of PV implantation; choice of the approach, percutaneous interventional vs.
Antonio F. Corno, Antonio F. Corno
doaj   +1 more source

Video_2_Case report: Right ventricular outflow tract obstruction caused by multicomponent mesenchymal tumor.AVI

, 2022
Right ventricular outflow tract obstruction (RVOTO) is a cause of hemodynamic instability that can lead to right ventricular dysfunction. Cardiac tumors located in the right ventricle or surrounding structures can cause RVOTO.
Shengyuan Huang (13776577), Shiye Wang (13776580), Zhixiang Tang (4397125), Yinghuan Dai (12879608), Long Song (4251634)   +4 more
core   +1 more source

Combined Karyotyping, Copy Number Variation Sequencing, and Whole Exome Sequencing in the Prenatal Diagnosis of Congenital Heart Disease: Detection Rates and Phenotypic Associations

Journal of Clinical Laboratory Analysis, EarlyView.
This study combined karyotyping, copy number variation sequencing, and whole‐exome sequencing to assess the value of genetic testing in the prenatal diagnosis of congenital heart disease (CHD) and to evaluate the relationship between genetic variants and prenatal phenotypes.
Jieqiong Xie, Yanru Huang, Xingmei Yao, Lutan Zhang, Yixi Zhou, Wenbo Wang, Jian Zhang, Yunsheng Ge   +7 more
wiley   +1 more source

Nova técnica: translocação aórtica e pulmonar com preservação da valva pulmonar New technique: aortic and pulmonary translocation with preservation of pulmonary valve

Brazilian Journal of Cardiovascular Surgery, 2010
Realizamos com sucesso novo procedimento cirúrgico, em duas crianças portadoras de transposição das grandes artérias associada a comunicação interventricular e obstrução da via de saída do ventrículo esquerdo.
Gláucio Furlanetto, Sandra S Henriques, Flavia S Pasquinelli, Beatriz H. S Furlanetto   +3 more
doaj   +1 more source